ArticlePhysiological reports2026
Voluntary wheel running attenuates peptidoglycan-polysaccharide-induced inflammation and preserves skeletal muscle remodeling in male C57BL/6J mice.
Article in Physiological reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Voluntary wheel running behavior is reduced by SARS-CoV-2 S1 administration and mitigates hypothalamic neuroinflammatory processes.Brain, behavior, & immunity - health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Chronic systemic inflammation (CSI) is associated with skeletal muscle dysfunction and may impair adaptive responses. This study investigated whether skeletal muscle responses to voluntary wheel running (VWR) are maintained following exposure to CSI. Twelve-week-old male C57BL/6J mice were assigned to Saline+Sedentary, Peptidoglycan-Polysaccharide (PG-PS) + Sedentary, Saline+Exercise, and PG-PS + Exercise groups (n = 12 per group), with PG-PS used to induce CSI. Following 3 weeks of intervention, blood and lower-leg skeletal muscles were collected. Total running distance did not differ between exercise groups. PG-PS administration increased serum tumor necrosis factor-α and interleukin-1β levels in sedentary mice, whereas these levels were attenuated in VWR mice. Under sedentary conditions, soleus muscle weight and fiber cross-sectional area (CSA) were lower in PG-PS-treated mice. Exercise was associated with higher soleus muscle mass and fiber CSA in both saline- and PG-PS-treated mice. PG-PS increased 4-hydroxynonenal levels in the soleus muscle, whereas VWR was associated with lower levels. VWR markedly increased muscle protein synthesis and reduced markers of muscle protein breakdown, indicating enhanced protein turnover independent of PG-PS treatment. These findings suggest that exercise-induced increases in muscle mass and fiber size occur independent of PG-PS treatment. Clinically, whole-body exercise may represent a physiologically relevant, non-pharmacological strategy to support skeletal muscle health under chronic inflammatory conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.